Eric Aguiar, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 7,074 shares at $55.13 ($390K) on 2019-12-16, disclosed to the SEC on 2019-12-18.
Open-market sale of $390k BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.13 | 3,537 | $195K | 50.0% |
| 2 | $55.13 | 3,537 | $195K | 50.0% |
| Total | $55.13 avg | 7,074 | $390K | 100% |
| Filing → |
| NVTA | SELL | 2020-07-16 | $680K | — | Filing → |
| BHVN | SELL | 2020-01-24 | $114K | — | Filing → |
| BHVN | SELL | 2020-01-10 | $1.7M | — | Filing → |